Do You Need Progesterone? - Dr Mary Claire Haver

Progesterone in HRT: More Than Just Uterine Protection

Progesterone often gets treated as the obligatory add-on in hormone replacement therapy. You need estrogen for symptoms, and if you have a uterus, you throw in progesterone to keep the lining safe. But Dr. Mary Claire Haver, in conversation with Dr. Gabrielle Lyon, makes a compelling case that progesterone deserves far more respect and attention than that. It is more than a safety net for the endometrium. It is a hormone with wide-ranging effects on sleep, mood, anxiety, brain health, and metabolic function, and understanding those effects changes how you think about your HRT protocol.

Progesterone levels begin declining in perimenopause, often before estrogen does. In fact, some of the earliest perimenopausal symptoms, including anxiety, insomnia, irritability, and irregular bleeding, are driven more by progesterone loss than by estrogen decline. Many women in their early 40s with regular or near-regular periods are already progesterone-deficient, and this goes unrecognized because their estrogen levels look normal and they have not yet missed periods.

How Progesterone Affects Your Brain and Sleep

Progesterone is a neurosteroid. That means it directly affects brain function. It binds to GABA receptors, the same receptors targeted by anti-anxiety medications and sleep aids. This is why progesterone has a natural calming, anxiolytic, and sedating effect. Women who take micronized progesterone at bedtime often report improved sleep quality within days, not because of a placebo effect, but because of a direct pharmacological action on brain chemistry.

The loss of progesterone during perimenopause helps explain why so many women develop anxiety and insomnia during this transition, often for the first time in their lives. They end up on SSRIs, benzodiazepines, or sleep medications when the underlying issue is hormonal. Dr. Haver is not suggesting that every case of perimenopausal anxiety is purely a progesterone problem, but she is making the case that it should be considered and tested for before jumping to other treatments.

Allopregnanolone, a metabolite of progesterone, is one of the most potent natural anxiolytics your body produces. When progesterone declines, allopregnanolone declines with it, and the brain loses one of its key self-regulating mechanisms for stress and anxiety. Replacing progesterone restores this pathway. This is not theoretical; the FDA-approved postpartum depression drug brexanolone (Zulresso) works precisely because it is a synthetic version of allopregnanolone. The connection between progesterone and brain function is well-established science.

The Uterine Protection Piece

The traditional role of progesterone in HRT is to oppose estrogen's stimulatory effect on the endometrial lining. Estrogen alone, in a woman who still has her uterus, can cause the lining to thicken excessively (endometrial hyperplasia), which over time can progress to endometrial cancer. Adding progesterone prevents this by promoting regular shedding of the lining or keeping it thin.

This is well-established and non-negotiable for women with a uterus on estrogen therapy. But here is where it gets interesting: what about women who have had a hysterectomy? Traditional guidelines say they do not need progesterone since there is no endometrial lining to protect. Dr. Haver suggests that this view is too narrow. Given progesterone's effects on the brain, sleep, and mood, there are good reasons to consider it for post-hysterectomy women as well. The decision should be based on the full spectrum of progesterone's benefits, not solely on its endometrial role.

Micronized vs. Synthetic: A Critical Distinction

Not all progesterone products are equivalent. Micronized progesterone, the form that is bioidentical to what your body produces, has a markedly different effect profile than synthetic progestins. Medroxyprogesterone acetate (MPA), the synthetic progestin used in the WHI study, does not provide the same neurological benefits as micronized progesterone and has been associated with less favorable breast cancer outcomes in some analyses.

This distinction matters enormously. When someone says "progesterone increases breast cancer risk," they are usually referring to data on synthetic progestins, not micronized progesterone. The French E3N cohort study, one of the largest prospective studies on this question, found no increased breast cancer risk with micronized progesterone used alongside estrogen for up to 5 years. The risk signal was present with synthetic progestins. These are different molecules with different effects, and conflating them does women a disservice.

Dr. Haver recommends micronized progesterone (Prometrium or compounded) as the standard of care for HRT. The typical dose is 100 to 200 mg taken orally at bedtime. The 200 mg dose is commonly used for women who still have a uterus, while 100 mg may be considered for post-hysterectomy women seeking the neurological and sleep benefits. Some women use progesterone cyclically (10-14 days per month) while others use it continuously. The approach depends on the individual's clinical situation and provider preference.

Signs You Might Be Progesterone-Deficient

If you are in your late 30s or 40s and experiencing new-onset anxiety, sleep disruption, irritability, heavier or more frequent periods, or PMS symptoms that are worse than they used to be, progesterone deficiency is worth investigating. A serum progesterone level drawn on day 21 of your cycle (about a week after ovulation, if you are still ovulating) can give useful information, though it is an imperfect marker since progesterone is produced in pulses and levels fluctuate throughout the day.

Symptom assessment alongside lab work gives the best picture. Track your sleep quality, anxiety levels, mood changes, and menstrual patterns over two to three cycles before your appointment. This data helps your provider see the pattern and makes it easier to determine whether a progesterone trial is warranted.

The question of cycling versus continuous progesterone use is something many women wonder about. Cyclical use, taking progesterone for 10 to 14 days per month, mimics the natural menstrual cycle pattern and may produce a monthly withdrawal bleed. Continuous use, taking progesterone every day, is more common in postmenopausal women and typically avoids bleeding after an initial adjustment period. Both approaches provide endometrial protection, and the choice often comes down to provider preference and patient tolerance. Some women feel better on cyclical dosing because it more closely mirrors their premenopausal physiology. Others prefer the simplicity and bleeding avoidance of continuous use.

Dr. Haver also addresses the compounding pharmacy question that comes up frequently. Compounded progesterone is often marketed as being identical to brand-name micronized progesterone, and in many cases the active ingredient is the same. However, compounded products are not subject to the same quality control testing and regulatory oversight as FDA-approved medications. This does not mean compounded progesterone is unsafe or ineffective, but it does mean there is more variability between batches and pharmacies. When FDA-approved micronized progesterone (Prometrium) is available and affordable, it is generally the preferred option. When custom dosing or alternative delivery forms are needed, a reputable compounding pharmacy with third-party testing is the way to go.

Topical progesterone creams sold over the counter deserve separate mention because they are widely available and heavily marketed to menopausal women. The problem is that topical progesterone absorption is highly variable and unpredictable. Blood levels achieved through skin application are often insufficient to provide reliable endometrial protection, which means women using topical progesterone cream as their sole progesterone source alongside estrogen may not actually be protecting their endometrium. This is a safety concern that Dr. Haver is clear about: over-the-counter progesterone cream should not be relied upon as a substitute for prescription micronized progesterone in women using systemic estrogen therapy.

The emerging research on progesterone's effects on breast tissue is also worth knowing. While synthetic progestins have been associated with increased breast density and potentially increased breast cancer risk in some studies, micronized progesterone appears to have a neutral or even protective effect on breast tissue. The E3N study data showing no increased breast cancer risk with micronized progesterone at five years is reassuring, though longer-term data continues to be collected and analyzed. This distinction between synthetic and bioidentical progesterone in terms of breast safety is one more reason why the type of progesterone prescribed matters, more than whether progesterone is included in the protocol.

The Bigger Picture of Hormone Balance

Dr. Haver's core message is that progesterone is a foundational hormone, not an afterthought. Its decline is one of the earliest and most impactful changes of the menopausal transition, and replacing it can address symptoms that women and their doctors often attribute to stress, aging, or psychiatric conditions. The shift from viewing progesterone as merely "uterine protection" to recognizing it as a critical player in brain health, sleep regulation, and emotional stability represents a meaningful evolution in how we approach women's hormone health.

If you are on estrogen-only therapy and still struggling with sleep or anxiety, ask your provider about adding micronized progesterone. If you have had a hysterectomy and were told you do not need progesterone, consider whether the neurological benefits might be worth exploring. And if you are not yet on HRT but dealing with the early symptoms of perimenopause, progesterone may be the first hormone worth addressing. The conversation is shifting, and Dr. Haver is helping lead that shift toward a more complete understanding of what women's bodies actually need.